NXTC Stock Analysis: Buy, Sell, or Hold?
NXTC - NextCure, Inc. Common Stock
$6.58
4.40 (201.83%)
▲
5d:
+269.66%
30d:
+195.07%
90d:
-46.59%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When NXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NXTC is 115.7% above its trading range ($3.05). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NXTC is 115.7% above its trading range ($3.05). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NXTC is currently trading at $6.58, which is considered extended relative to its 30-day fair value range of $1.30 to $3.05.
Technical Outlook: Technically, NXTC is in a downtrend. Immediate support is located at $2.28, while resistance sits at $7.55. The stock is showing strong short-term momentum, up 201.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+786.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NXTC is in a downtrend. Immediate support is located at $2.28, while resistance sits at $7.55. The stock is showing strong short-term momentum, up 201.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+786.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.30 -
$3.05
Company Quality Score
43/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+115.7% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+201.8%)
- BULLISH: Trading 786.8% below Wall St target ($19.33)
Trading Range Analysis
30-Day Trading Range
$1.30 -
$3.05
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.28
Resistance Level
$7.56
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$19.33
(+786.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 14, 2026 4:17 PM ET
Data refreshes hourly during market hours. Next update: 5:17 PM
Data refreshes hourly during market hours. Next update: 5:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
